250 related articles for article (PubMed ID: 24510342)
1. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer.
Yoda Y; Takeshima H; Niwa T; Kim JG; Ando T; Kushima R; Sugiyama T; Katai H; Noshiro H; Ushijima T
Gastric Cancer; 2015 Jan; 18(1):65-76. PubMed ID: 24510342
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer.
Yamaguchi T; Mukai H; Yamashita S; Fujii S; Ushijima T
Oncology; 2015; 88(6):377-84. PubMed ID: 25591616
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.
Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T
Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304
[TBL] [Abstract][Full Text] [Related]
4. [Genetic and epigenetic alterations in gastric carcinogenesis].
Ushijima T; Yoshida S
Nihon Rinsho; 2012 Oct; 70(10):1705-14. PubMed ID: 23198549
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers.
Kim JG; Takeshima H; Niwa T; Rehnberg E; Shigematsu Y; Yoda Y; Yamashita S; Kushima R; Maekita T; Ichinose M; Katai H; Park WS; Hong YS; Park CH; Ushijima T
Cancer Lett; 2013 Mar; 330(1):33-40. PubMed ID: 23196062
[TBL] [Abstract][Full Text] [Related]
6. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
7. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis.
Yang HJ; Kim SG; Lim JH; Choi JM; Kim WH; Jung HC
Gastric Cancer; 2018 Mar; 21(2):237-248. PubMed ID: 28643146
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes and functional study of HOXA11 in human gastric cancer.
Cui Y; Gao D; Linghu E; Zhan Q; Chen R; Brock MV; Herman JG; Guo M
Epigenomics; 2015; 7(2):201-13. PubMed ID: 25590359
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the Canonical and Non-canonical Wnt Signaling Pathways in Gastric Cancer.
Wang L; Wang H; Duan X; Dai P; Li J
Dig Dis Sci; 2019 Oct; 64(10):2830-2842. PubMed ID: 30997579
[TBL] [Abstract][Full Text] [Related]
14. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer.
Wang J; Xiu J; Baca Y; Battaglin F; Arai H; Kawanishi N; Soni S; Zhang W; Millstein J; Salhia B; Goldberg RM; Philip PA; Seeber A; Hwang JJ; Shields AF; Marshall JL; Astsaturov I; Craig Lockhart A; Gatalica Z; Michael Korn W; Lenz HJ
Oncogene; 2021 Jul; 40(30):4894-4905. PubMed ID: 34163031
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of gastric carcinoma.
Jang BG; Kim WH
Pathobiology; 2011; 78(6):302-10. PubMed ID: 22104201
[TBL] [Abstract][Full Text] [Related]
18. Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.
Waraya M; Yamashita K; Ema A; Katada N; Kikuchi S; Watanabe M
PLoS One; 2015; 10(10):e0139902. PubMed ID: 26447864
[TBL] [Abstract][Full Text] [Related]
19. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation and Genetic Aberrations in Gastric Cancer.
Usui G; Matsusaka K; Mano Y; Urabe M; Funata S; Fukayama M; Ushiku T; Kaneda A
Digestion; 2021; 102(1):25-32. PubMed ID: 33070127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]